Direct cancer injection tested in early trial
Disease control
Terminated
This early-phase study tested a new treatment called BT-001, which is injected directly into tumors. It was given alone and combined with an existing immunotherapy drug (pembrolizumab) to people with advanced cancers that had spread. The main goals were to find a safe dose and se…
Phase: PHASE1, PHASE2 • Sponsor: Transgene • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC